Grigoris Gerotziafas: Join Our Workshop on Advancing Guideline Adoption in Cancer-Associated Thrombosis at ISTH 2026
Grigoris Gerotziafas, Director of the Cancer, Vessels, Biology, and Therapeutics (CaVITE) Research Department, Head of the CRSA at Sorbonne University, shared on LinkedIn:
”Join us at ISTH 2026 in Paris for a high-level international partnered workshop
From Evidence to Implementation: Advancing Guideline Adoption in Cancer-Associated Thrombosis
10 July 2026 | 15:00–19:30 | Paris
Despite major advances in evidence and international recommendations, the implementation of guidelines for ‘cancer-associated thrombosis (CAT)’ prevention and treatment remains inconsistent across healthcare systems.
This interactive workshop is organized by CaVITE (CRSA, INSERM U938, Sorbonne University) in collaboration with ICTHIC and will bring together
international experts, clinicians, researchers, healthcare professionals, policymakers, and key stakeholders to discuss practical solutions for translating evidence and guidelines into real-world practice.
The roundtable aims to initiate a ‘Roadmap for improving CAT guideline implementation worldwide’.
We warmly invite physicians, fellows, nurses, pharmacists, researchers, policymakers, and healthcare stakeholders to join this important discussion.
Please share within your professional networks.”
Stay updated with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian